Leiomodin 1 (LMOD1) is a protein that plays a critical role in the regulation of actin filament dynamics, particularly in smooth muscle and non-muscle cells. Functionally, it acts as a nucleator, promoting the assembly of actin filaments, which are fundamental components of the cytoskeleton. This activity is essential for various cellular processes, including cell division, motility, and maintenance of cell shape. LMOD1's ability to nucleate actin assembly is vital for the proper organization and functionality of the actin cytoskeleton, impacting cellular architecture and intracellular transport. The protein's unique structure enables it to bind to actin monomers, facilitating the formation of actin filaments by accelerating the nucleation phase, which is the rate-limiting step in filament assembly. Thus, LMOD1 is integral to the dynamic equilibrium of actin polymerization and depolymerization that underlies cellular adaptability and response to physiological cues.
The inhibition of LMOD1 can disrupt the normal dynamics of actin filament assembly, leading to altered cytoskeletal structure and compromised cellular functions. Inhibition may occur through various mechanisms, including the direct binding of inhibitory molecules that block LMOD1's actin-binding sites, preventing it from interacting with actin monomers. This interaction is crucial for its nucleation activity; therefore, blocking these sites can effectively reduce the rate of new filament formation. Another potential mechanism involves post-translational modifications of LMOD1, such as phosphorylation or ubiquitination, which could alter its structure, stability, or affinity for actin, thereby inhibiting its nucleating function. Additionally, changes in the expression levels of LMOD1 through transcriptional regulation or mRNA stability could also serve as a means of inhibition, impacting the cellular concentration of LMOD1 and thus its capacity to promote actin polymerization. Such mechanisms of inhibition highlight the intricate control of actin cytoskeleton dynamics and underscore the importance of LMOD1 in maintaining cellular structure and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May demethylate the LMOD1 gene promoter, potentially influencing gene expression regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Could inhibit histone deacetylases, affecting chromatin structure and LMOD1 transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Might intercalate DNA, blocking the transcription of LMOD1. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Might inhibit LMOD1 translation by blocking ribosomal translocation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Could inhibit proteasomal degradation, indirectly affecting LMOD1 protein levels. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
May inhibit JNK, potentially affecting AP-1 mediated LMOD1 transcription. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Could inhibit p38 MAPK, possibly affecting LMOD1 expression under stress conditions. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Might inhibit ROCK, potentially affecting actin dynamics and LMOD1 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
May inhibit MEK, potentially affecting ERK-mediated LMOD1 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Could inhibit PI3K, potentially affecting Akt-mediated LMOD1 stability. | ||||||